Related Experiment Video
Updated: Sep 17, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
707
Immune regeneration: implications for cancer immunotherapy and beyond
The Journal of Clinical Investigation
|July 1, 2025
Summary
T cell regeneration is key for cancer immunotherapy and autoimmune diseases. Understanding how T cells balance self-renewal and differentiation offers new therapeutic strategies for these conditions.
Area of Science:
- Immunology
- Cancer Biology
- Regenerative Medicine
Background:
- Cancer immunotherapies utilize T lymphocytes to target tumor cells.
- T cell immunity is increasingly understood as a regenerative process.
- T cells must balance self-renewal and differentiation, akin to stem cells.
Purpose of the Study:
- To explore the role of T cell regeneration in cancer immunotherapy resistance.
- To investigate how lymphocyte regeneration impacts autoimmune diseases.
- To identify strategies for modulating T cell self-renewal for therapeutic benefit.
Main Methods:
- Analysis of recent discoveries in lymphocyte-dependent immunity.
- Examination of signaling pathways influencing T cell metabolism and fate.
- Review of emerging studies on T cell self-renewal and immunotherapy response.
Main Results:
- Durable immunotherapy response may be limited by the number of self-renewing T cells.
- T cell differentiation and self-renewal are influenced by activating and inhibitory signals.
- Lopsided information transfer between sibling cells contributes to alternative cell fates.
Conclusions:
- Leveraging regenerative signaling can enhance sustained T cell output to overcome cancer immunotherapy resistance.
- Modulating T cell regeneration offers potential therapeutic strategies for both cancer and autoimmune diseases.
- Undercutting self-renewal of pathogenic T cell clones may be a strategy for treating autoimmune conditions.
Related Concept Videos
01:27Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
01:30Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:27Cytotoxic T Cells-mediated Immune Response
2.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.4K
02:38Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K